IST:BIOEN Income Statement

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,943	3,560	3,224	2,338	427.7
Revenue Growth (YoY)	-17.33%	10.42%	37.91%	446.57%	74.36%
Operations & Maintenance	59.66	69.48	69.5	50.97	10.27
Selling, General & Admin	642.39	623.92	456.4	249.27	42.47
Other Operating Expenses	2,803	3,567	2,638	1,486	286.45
Total Operating Expenses	3,505	4,260	3,164	1,787	339.19
Operating Income	-562.33	-700.27	59.72	551.03	88.51
Interest Expense	-581.95	-658.32	-441.46	-106.86	-31.55
Interest Income	35.09	212.62	123.46	15.9	25.71
Net Interest Expense	-546.86	-445.71	-318	-90.96	-5.84
Income (Loss) on Equity Investments	-8.85	-145.94	142.18	41.05	25.74
Currency Exchange Gain (Loss)	-735.08	-621.57	109.91	-272.02	-77.32
Other Non-Operating Income (Expenses)	1,140	1,756	1,361	463.03	-2.46
EBT Excluding Unusual Items	-713.1	-157.3	1,355	692.13	28.64
Gain (Loss) on Sale of Investments	-76.55	-0.03	-12.15	-	-
Insurance Settlements	13.62	41.42	-	-	-
Legal Settlements	4.01	-1.87	-2.6	-6.85	-5.22
Pretax Income	-772.01	-117.78	1,340	685.28	23.42
Income Tax Expense	610.29	-30.22	-31.79	108.73	19.43
Earnings From Continuing Ops.	-1,382	-87.56	1,372	576.56	4
Minority Interest in Earnings	-	-	-2.87	0.2	2.55
Net Income	-1,382	-87.56	1,369	576.76	6.54
Net Income to Common	-1,382	-87.56	1,369	576.76	6.54
Net Income Growth	-	-	137.34%	8716.24%	-87.04%
Shares Outstanding (Basic)	500	500	500	500	500
Shares Outstanding (Diluted)	500	500	500	500	500
Shares Change (YoY)	-	-	-	-	17.19%
EPS (Basic)	-2.76	-0.18	2.74	1.15	0.01
EPS (Diluted)	-2.76	-0.18	2.74	1.15	0.01
EPS Growth	-	-	137.34%	8716.25%	-88.94%
Free Cash Flow	153.69	-2,372	100.46	-354.09	-767.25
Free Cash Flow Per Share	0.31	-4.74	0.20	-0.71	-1.53
Profit Margin	-46.97%	-2.46%	42.46%	24.67%	1.53%
Free Cash Flow Margin	5.22%	-66.63%	3.12%	-15.15%	-179.39%
EBITDA	213.54	48.32	617.65	831.54	119.87
EBITDA Margin	7.26%	1.36%	19.16%	35.57%	28.03%
D&A For EBITDA	775.87	748.58	557.93	280.5	31.35
EBIT	-562.33	-700.27	59.72	551.03	88.51
EBIT Margin	-19.11%	-19.67%	1.85%	23.57%	20.70%
Effective Tax Rate	-	-	-	15.87%	82.94%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.